SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-23-001035
Filing Date
2023-06-27
Accepted
2023-06-27 07:01:18
Documents
26
Period of Report
2023-06-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALDEYRA THERAPEUTICS, INC. 8-K a53433819.htm   iXBRL 8-K 36869
2 EXHIBIT 99.1 a53433819ex99_1.htm EX-99.1 27789
3 EXHIBIT 99.2 a53433819ex99_2.htm EX-99.2 14543
7 a53433819ex99_1slide13.jpg GRAPHIC 129683
8 a53433819ex99_1slide14.jpg GRAPHIC 382682
9 a53433819ex99_1slide15.jpg GRAPHIC 226365
10 a53433819ex99_1slide16.jpg GRAPHIC 159090
11 a53433819ex99_1slide17.jpg GRAPHIC 185171
12 a53433819ex99_1slide18.jpg GRAPHIC 128457
13 a53433819ex99_1slide19.jpg GRAPHIC 120636
14 a53433819ex99_1slide20.jpg GRAPHIC 165678
15 a53433819ex99_1slide21.jpg GRAPHIC 165961
16 a53433819ex99_1slide22.jpg GRAPHIC 109484
17 a53433819ex99_1slide23.jpg GRAPHIC 143016
18 a53433819ex99_1slide24.jpg GRAPHIC 160009
  Complete submission text file 0001157523-23-001035.txt   3092354

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aldx-20230627.xsd EX-101.SCH 3862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20230627_lab.xml EX-101.LAB 22546
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20230627_pre.xml EX-101.PRE 16042
20 EXTRACTED XBRL INSTANCE DOCUMENT a53433819_htm.xml XML 4233
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 231043963
SIC: 2834 Pharmaceutical Preparations